@article{Taylor_K-2024_184256,
title = {Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people},
author = {Taylor, K. and Eastwood, S. and Walker, V. and Cezard, G. and Knight, R. and Al Arab, M. and Wei, Y. and Horne, E. and Teece, L. and Forbes, H. and Walker, A. and Fisher, L. and Massey, J. and Hopcroft, L. and Palmer, T. and Cuitun Coronado, J. and Ip, S. and Davy, S. and Dillingham, I. and Morton, C. and Greaves, F. and Macleod, J. and Goldacre, B. and Wood, A. and Chaturvedi, N. and Sterne, J. and Denholm, R.},
month = {jul},
year = {2024},
abstract = {BackgroundSome studies have shown that the incidence of type 2 diabetes increases after a diagnosis of COVID-19, although the evidence is not conclusive. However, the effects of the COVID-19 vaccine on this association, or the effect on other diabetes subtypes, are not clear. We aimed to investigate the association between COVID-19 and incidence of type 2, type 1, gestational and non-specific diabetes, and the effect of COVID- 19vaccination, up to 52 weeks after diagnosis.},
pages = {558-568},
volume = {12},
issue = {8},
journal = {The Lancet Diabetes & Endocrinology},
publisher = {Elsevier},
url = {https://doi.org/10.1016/S2213-8587(24)00159-1},
}
